Edaravone

FDA Approved: * May 6, 2024
Pharm Company: * HIKMA PHARMACEUTICALS USA INC
Category: Neurological Disorders

Edaravone, sold as under the brand names Radicava and Radicut among others, is an intravenous medication used to help with recovery following a stroke and to treat amyotrophic lateral sclerosis (ALS).[1][2] The label carries a warning about the potential for hypersensitivity reactions to edaravone, and adverse effects include bruising, gait disturbances, headache, skin inflammation, eczema, problems breathing, excess sugar in urine, and fungal skin infections.&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Edaravone 30 mg/100ml Intravenous Injection, Solution
NDC: 68083-500
Labeler:
Gland Pharma Limited
Edaravone 60 mg/100ml Intravenous Injection, Solution
NDC: 68083-501
Labeler:
Gland Pharma Limited

Related Brands

Drugs with the same active ingredients